Dow, S&P 500, Nasdaq Futures Gain As Trump Signals Iran Talks Could Resume: Why SNDK, BMNR, ORCL, BE, TVTX Kept Traders On Edge Today
U.S. stock futures rose late Monday as President Trump signaled Iran may resume talks. The S&P 500 erased earlier losses, closing at 6,886.24. BlackRock upgraded U.S. equities to 'Overweight.' SanDisk (SNDK) hit a record high after positive analyst ratings. Bitmine (BMNR) gained on increased Ethereum holdings. Oracle (ORCL) and Bloom Energy (BE) rose on AI and cloud infrastructure news. Travere (TVTX) slipped despite FDA approval. Credo (CRDO) jumped on acquisition plans.
How this was made
The 30-second read
Why it matters
The combination of geopolitical optimism and multiple company-specific catalysts drove a broad market uptick.
Market read
The article links macro geopolitical news with several fresh corporate developments, creating short‑term trading opportunities.
What to watch
Rising oil prices may offset gains in tech stocks if energy costs stay high.
Background
Futures markets reacted to President Trump's comments on Iran negotiations, lifting risk sentiment.
Ticker impact
SanDisk hit a fresh record high after Evercore initiated coverage with an Outperform rating and a $1,200 price target.
Bullish, could see further gains if coverage expands.
Upgrade and high target suggest strong demand for storage, supporting price appreciation.
Bitmine Immersion added 71,534 ETH, raising its holdings to 4% of circulating supply, aiming for 5%.
Modest upside if ETH price rises.
Large ETH accumulation signals confidence in crypto market, likely supporting share price.
Oracle jumped 13% on hopes of a U.S.-Iran peace deal and a rebound in software stocks.
Potential continuation if peace talks progress.
Market sentiment around the stock is bullish due to macro catalyst.
Bloom Energy announced an expanded agreement to support Oracle’s AI and cloud infrastructure buildout.
Likely modest upside on contract news.
Strategic partnership with Oracle adds credibility and potential growth.
Travere Therapeutics received FDA approval for Filspari to treat focal segmental glomerulosclerosis.
Potential upside as market prices in future sales.
FDA approval is a key catalyst for biotech valuation.
Credo Technology agreed to acquire DustPhotonics for $750 million cash plus stock.
Bullish, as the deal may enhance growth prospects.
Strategic M&A can drive revenue expansion in a high‑growth segment.
Market effects
Positive sentiment for AI‑related hardware and software sectors.
U.S. futures rise on geopolitical optimism, supporting broader market risk appetite.
Potential easing of Iran tensions could benefit global energy and trade flows.
Counterpoint
If Iran talks stall again, the rally could reverse sharply.
Key entities
- political figureDonald Trump
Provided statements suggesting possible Iran negotiation resumption.
- political figureJ.D. Vance
Vice President who left talks without agreement.
